The Dana Farber Cancer Institute and the German Cancer Research Centre have joined the international Alliance for Cancer Early Detection (ACED) initiative, led by the OHSU Knight Cancer Institute, Cancer Research UK, University of Manchester, University College London, and the University of Cambridge. Incoming alliance chair Rebecca Fitzgerald said, “The next phase of the expanding ACED network is an exciting opportunity for collaborations in early cancer detection.”

Ben Burwitz, Ph.D., and his research team develop the first transgenic nonhuman primate model for studying hepatitis B virus. The breakthrough could lead to the development of new treatments for the disease, which affects about 250 million people globally and results in nearly 1 million deaths annually. Burwitz says, “We’ve seen success with treatments for hepatitis C that wipe out the virus, and that’s the goal here. Developing a drug that’s effective, easy to distribute and affordable for global populations is critical.”

In a TCTMD story about a new drug to treat transthyretin amyloid cardiomyopathy, Ahmad Masri, M.D., says, “We went from a condition that was 100% fatal, untreatable, and no approved medications to now having a couple. This is a very early real-world study done right around the time of approval and we’re already seeing there are signals where mortality looks better than what we have expected.”

Media cover potential impacts to OHSU, Oregon and scientific research in the U.S. if the NIH reduction of indirect costs holds. “There’s 1,900 research workers at OHSU and I don’t think any of them feel safe. I know I don’t feel safe,” says Lynne Swarbrick, B.S.

Researchers at Oregon Health & Science University have developed a test called PAC-MANN, the abbreviation for “protease activity-based assay using a magnetic nanosensor,” which uses a small blood sample to detect changes in protease activity — a key indicator of pancreatic ductal adenocarcinoma, or PDAC, the most common and deadly form of pancreatic cancer.

The Oregon Poison Center reminds the public about the risk of carbon monoxide poisoning during a dip in temperatures and persistent winter weather across the state. “This is the perfect time to check your battery-operated carbon monoxide detector or install one on every level of your home if you haven’t already done so,” says Rob Hendrickson, M.D. “If you need to use a generator or alternative cooking source, it is extremely important to place them outside, well away from windows, doors and ventilation systems.”

A team of OHSU researchers led by Jared Fischer, Ph.D., and Jose Montoya Mira, Ph.D., have developed a new blood test that identifies hard-to-detect pancreatic cancer with 85% accuracy. Fischer says, “The problem with pancreatic cancer is that we often catch it too late. Our goal with PAC-MANN is to give clinicians a tool that can detect the disease much earlier, when more treatment options are available and there is a better chance of survival.”

A team of OHSU researchers led by Jared Fischer, Ph.D., and Jose Montoya Mira, Ph.D., have developed a new blood test that identifies hard-to-detect pancreatic cancer with 85% accuracy. Fischer says, “The problem with pancreatic cancer is that we often catch it too late. Our goal with PAC-MANN is to give clinicians a tool that can detect the disease much earlier, when more treatment options are available and there is a better chance of survival.”

A team of OHSU researchers led by Jared Fischer, Ph.D., and Jose Montoya Mira, Ph.D., have developed a new blood test that identifies hard-to-detect pancreatic cancer with 85% accuracy. Fischer says, “The problem with pancreatic cancer is that we often catch it too late. Our goal with PAC-MANN is to give clinicians a tool that can detect the disease much earlier, when more treatment options are available and there is a better chance of survival.”

Media cover potential impacts to OHSU, Oregon and scientific research in the U.S. if the NIH reduction of indirect costs holds. “There’s 1,900 research workers at OHSU and I don’t think any of them feel safe. I know I don’t feel safe,” says Lynne Swarbrick, B.S.